Are we toasting to a future where weight loss is as easy as popping a pill? In our latest chat, we bare all about America's obesity crisis, the promises of a new drug, Ozempic, and our skepticism of quick fixes. As we talk about the alarming rates of obesity and the health risks it poses, we challenge the usefulness of BMI as a measure of obesity, igniting a conversation about real solutions and personal experiences with diet and exercise.

Ozempic is making waves as the touted solution to weight loss. But how much do we know about it? We strip down this complex world of weight loss drugs, revealing the potential benefits, risks, and our concerns about misuse. We delve into the world of off-label prescriptions for weight loss. As Ozempic’s popularity skyrockets among those desperate to shed pounds, so do ethical concerns. From soaring prices and shortages to the role of anti-aging doctors and compounding pharmacies in its distribution, we unpack it all. We also give a voice to those who argue Ozempic should only be available for diabetics and others who champion its benefits for those struggling with obesity-related health issues. Join us as we navigate the intricate issues surrounding Ozempic and its impact on the weight loss industry.

Support the show

Follow The I'm Not Dumb But Podcast

https://www.youtube.com/@ImNotDumbButPodcast

https://twitter.com/ImNotDumbBut

https://www.instagram.com/imnotdumbbutpod/